KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Organon (OGN) Research & Development (2020 - 2025)

Organon has reported Research & Development over the past 6 years, most recently at $91.0 million for Q4 2025.

  • Quarterly results put Research & Development at $91.0 million for Q4 2025, down 30.0% from a year ago — trailing twelve months through Dec 2025 was $366.0 million (down 27.67% YoY), and the annual figure for FY2025 was $366.0 million, down 21.96%.
  • Research & Development for Q4 2025 was $91.0 million at Organon, up from $84.0 million in the prior quarter.
  • Over the last five years, Research & Development for OGN hit a ceiling of $170.0 million in Q1 2024 and a floor of $27.0 million in Q2 2022.
  • Median Research & Development over the past 5 years was $103.0 million (2021), compared with a mean of $106.6 million.
  • Biggest five-year swings in Research & Development: plummeted 64.47% in 2022 and later soared 374.07% in 2023.
  • Organon's Research & Development stood at $110.0 million in 2021, then increased by 29.09% to $142.0 million in 2022, then decreased by 5.63% to $134.0 million in 2023, then fell by 2.99% to $130.0 million in 2024, then decreased by 30.0% to $91.0 million in 2025.
  • The last three reported values for Research & Development were $91.0 million (Q4 2025), $84.0 million (Q3 2025), and $95.0 million (Q2 2025) per Business Quant data.